A novel approach in oligonucleotide analysis has disrupted the traditional methods, paving the way for a significant leap in the biotech landscape. The brainchild of the brilliant mind, Fekete, this innovative method utilizes a dual ion-pairing gradient to enhance ion-pair reversed-phase separations of oligonucleotides. This groundbreaking technique not only deviates from traditional methodologies but also propels the field of oligonucleotide drug development to new heights.
The Fekete approach combines a weak hydrophilic ion-pairing reagent in the initial aqueous phase with a robust hydrophobic one in the subsequent organic-rich phase. This unique amalgamation facilitates significant improvements in resolution and selectivity, particularly for complex mixtures. The utilization of concave gradients and short columns catalyzes faster and high-resolution separations, thereby supporting the efficient analysis in oligonucleotide drug development. This technique heralds a new era in biotechnology, unlocking new possibilities and setting new benchmarks for the industry.
The recent presentation during the afternoon sessions of HPLC 2025 on June 15, 2025, served as a testament to the growing interest and the urgent need for advancements in oligonucleotide analysis. The session, chaired by the reputed Davy Guillarme from the University of Geneva, Switzerland, and Kelly Zhang from Genentech, USA, ended on a high note with a discussion on oligonucleotide analysis – a hot topic in separation science.
The session kicked-off with an enlightening talk by Dwight Stoll from Gustavus Adolphus College, Minnesota, USA. His presentation, entitled “Recent Developments in One- and Two-Dimensional Liquid Chromatography for Oligonucleotide Analysis: A Mix of Traditional Techniques and New Discoveries,” underscored the rising prominence of oligonucleotides in the biopharmaceutical field. The therapeutic potential of these molecules, including gene regulation and RNA-based vaccines, is increasingly being recognized. However, as these molecules become more structurally complex, the demand for reliable analytical techniques to evaluate their purity, identity, and stability has skyrocketed.
Stoll’s research focused on enhancing liquid chromatography (LC) methods for oligonucleotide separation. He emphasized the impact of column length on the separation of similar oligonucleotide structures. His findings suggest that standard columns (5–15 cm) perform well, but extending column length can dramatically improve resolution when elution parameters are meticulously optimized.
Fekete’s innovative approach not only aligns with Stoll’s findings but also goes a step further by highlighting the advantages of dual and ternary gradient strategies for method development in oligonucleotide analysis. His technique showcases the potential for further advancements in the field, thereby revolutionizing the industry.
In conclusion, Fekete’s novel dual ion-pairing gradient approach marks a significant departure from traditional methods and offers a promising avenue for efficient and high-resolution separations. As the biotech industry continues to explore the vast potential of oligonucleotides, techniques like these will undoubtedly play a pivotal role in shaping the future of oligonucleotide drug development. The Fekete method, with its increased resolution, selectivity, and speed, is poised to become the new standard in the field. It’s a thrilling time for biotechnology, and we eagerly anticipate the transformations this novel approach will bring.
Read more from chromatographyonline.com
